NCT02996773 2025-11-10Haploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineUniversity of ArizonaPhase 1 Completed50 enrolled
NCT03524235 2024-11-12Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLLCedars-Sinai Medical CenterPhase 1 Completed20 enrolled
NCT02168140 2024-02-13CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin LymphomaWake Forest University Health SciencesPhase 1 Completed16 enrolled
NCT02240719 2019-01-04Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic CancerUniversity of California, DavisPhase 1 Completed20 enrolled
NCT01110135 2017-05-24Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple MyelomaUniversity of WashingtonPhase 2 Completed43 enrolled 5 charts